U.S. markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
127.67-2.91 (-2.23%)
At close: 04:00PM EDT
127.67 0.00 (0.00%)
After hours: 07:44PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Bollinger Bands

Bollinger Bands

Previous Close130.58
Bid127.85 x 1100
Ask130.14 x 800
Day's Range125.38 - 129.81
52 Week Range117.64 - 169.98
Avg. Volume510,050
Market Cap8.002B
Beta (5Y Monthly)0.68
PE Ratio (TTM)N/A
EPS (TTM)-7.37
Earnings DateAug 03, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est199.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for JAZZ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Jazz Pharmaceuticals plc
    JAZZ: Lowering target price to $151.00JAZZ PHARMACEUTICALS PLC has an Investment Rating of BUY; a target price of $151.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • PR Newswire

    Jazz Pharmaceuticals to Present Advancements in Sleep Medicine at Psych Congress 2022

    Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present seven abstracts from across its neuroscience portfolio at the 35th annual Psych Congress 2022, being held September 17-20, 2022.

  • Motley Fool

    3 Top Pot Stocks to Watch in September

    All three of these cannabis-related stocks turned profits last quarter and have had strong revenue growth.

  • Insider Monkey

    Top 10 Stock Picks of Henrik Rhenman’s Rhenman Partners

    In this article, we discuss the top 10 stock picks of Henrik Rhenman’s Rhenman Partners. You can skip our comprehensive analysis of Rhenman Partners’ history, investment philosophy, and hedge fund performance and go directly to Top 5 Stock Picks of Henrik Rhenman’s Rhenman Partners. Founded by American biochemist and billionaire Henrik Rhenman in 2008, Rhenman […]